Read more

January 18, 2021
1 min read
Save

Top in cardiology: Drinking and atrial fibrillation risk, COVID-19 and HF

A recent study showed that one alcoholic drink per day may be enough to increase the risk for atrial fibrillation. It was the top story in cardiology last week.

Another top story was about an analysis that revealed nearly one in four hospitalized patients with heart failure and COVID-19 died during hospitalization.

Alcohol
Source: Adobe Stock

Read these and more top stories in cardiology below:

One drink per day may be enough to increase risk for AF

As little as one alcoholic drink per day may confer an elevated risk for the development of atrial fibrillation, regardless of age and other cardiovascular risk factors, according to a study published in the European Heart Journal. Read more.

Nearly 1 in 4 hospitalized patients with HF, COVID-19 die

Patients with heart failure and COVID-19 had a high risk for complications, with nearly one in four dying during hospitalization, researchers reported. Read more.

Controlled hypertension confers CV event risk, but physical activity may help

Controlled hypertension was associated with a higher risk for major adverse cardiac and cerebrovascular events and all-cause mortality compared with normotension, according to results published in Heart. Read more.

CV diagnostic testing down, ischemic heart disease deaths up during COVID-19 pandemic

Deaths associated with CVD rose during the onset of the COVID-19 pandemic in the U.S., and the elevated mortality may be associated with a global trend in reduced cardiovascular diagnostic testing during that time, researchers wrote. Read more.

Q&A: Clinical outcomes in CVD treatment ‘may not reflect what patients truly value’

There has been much discussion about patient-centered outcomes in CVD therapy and treatment, but little consensus exists as to their definition and value. In a study published in JAMA Network Open, researchers, along with patients, caregivers and clinicians, worked together to define five patient-defined adverse cardiovascular and non-cardiovascular events that may form a meaningful composite outcome from a patient perspective for use in clinical practice. Read more.